Clinical Trial Update: Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating the combination of amivantamab with carboplatin and paclitaxel for unresectable locally recurrent or m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Amivantamab (amivantamab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Head &Amp; Neck Cancer, Head &Amp; Neck Squamous Cell Carcinoma | Phase 2 | Status: ENROLLING_BY_INVITATION